Herbal/traditional Products - Belgium
Sales of herbal/traditional products were dampened by two factors in 2009. Firstly, a lot of consumers decided to cut out purchases of non-essential products, notably in herbal/traditional products, which are rarely prescribed and/or reimbursed. Secondly, the imminent settlement of the European legislation about functional claims and dietary supplements hampered product launch activity in 2009. Until the beginning of 2008, many manufacturers opted for products which offered more freedom in...
Euromonitor International's Herbal/Traditional Products Products in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Herbal/Traditional Analgesics, Herbal/Traditional Calming and Sleeping Products, Herbal/Traditional Child-Specific Dietary Supplements, Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies, Herbal/Traditional Dietary Supplements, Herbal/Traditional Digestive Remedies, Herbal/Traditional Medicated Skin Care, Herbal/Traditional Medicinal Teas, Herbal/Traditional Smoking Cessation Aids, Herbal/Traditional Tonics and Bottled Nutritive Drinks
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Herbal/Traditional Products Products in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Herbal/Traditional Analgesics, Herbal/Traditional Calming and Sleeping Products, Herbal/Traditional Child-Specific Dietary Supplements, Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies, Herbal/Traditional Dietary Supplements, Herbal/Traditional Digestive Remedies, Herbal/Traditional Medicated Skin Care, Herbal/Traditional Medicinal Teas, Herbal/Traditional Smoking Cessation Aids, Herbal/Traditional Tonics and Bottled Nutritive Drinks
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Herbal/traditional Products in Belgium
Euromonitor International
April 2010
List of Contents and Tables
Executive Summary
Below-average Yet Still Positive Performance in 2009
Positive But Also Backward Steps in Deregulation
Market Still Fragmented, Despite Growing Global Consolidation
Distribution Still Under the Control of Pharmacies
Lower Growth Expected in the Short Term
Key Trends and Developments
Consumer Health Affected by Consumers Planning Purchases More Carefully
Deregulation on the One Side, Tougher Legislation on the Other
No Time To Be Sick
More Children, More Older People But More Limited Impact of Demography
Back To Nature
No Real Wind of Change in Distribution for the Moment
More Favourable Ground for the Leading Players
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
A New Agency and New Measures To Shorten the Delay
Belgian Medicines Law Follows European Lead
De-listing Or De-reimbursement
Advertising
Legislation on Advertising Remains Restrictive
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Switch Climate
Regulation of Herbal Products
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Biodiphar NV SA
Strategic Direction
Key Facts
Summary 3 Biodiphar NV SA: Key Facts
Summary 4 Biodiphar NV SA: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 5 Biodiphar NV SA: Competitive Position 2008
Omega Pharma NV
Strategic Direction
Key Facts
Summary 6 Omega Pharma NV: Key Facts
Summary 7 Omega Pharma NV: Operational Indicators
Company Background
Production
Summary 8 Omega Pharma NV: Production Statistics 2005
Competitive Positioning
Summary 9 Omega Pharma NV: Competitive Position 2009
Patch Pharma SA
Strategic Direction
Key Facts
Summary 10 Patch Pharma NV SA: Key Facts
Summary 11 Patch Pharma NV SA: Operational Indicators
Company Background and Production
Competitive Positioning
Pharmaceutiques Trenker, Laboratoires
Strategic Direction
Key Facts
Summary 12 Pharmaceutiques Trenker, Laboratoires: Key Facts
Summary 13 Pharmaceutiques Trenker, Laboratoires: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 14 Pharmaceutiques Trenker, Laboratoires: Competitive Position 2009
Vemedia Pharma NV
Strategic Direction
Key Facts
Summary 15 Vemedia Pharma NV: Key Facts
Summary 16 Vemedia Pharma NV: Operational Indicators
Company Background
Production
Summary 17 Vemedia Pharma NV: Production Statistics 2009
Competitive Positioning
Summary 18 Vemedia Pharma NV: Competitive Position 2009
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Herbal/Traditional Products: Value 2004-2009
Table 13 Sales of Herbal/Traditional Products: % Value Growth 2004-2009
Table 14 Herbal/Traditional Products Company Shares 2005-2009
Table 15 Herbal/Traditional Products Brand Shares 2006-2009
Table 16 Forecast Sales of Herbal/Traditional Products: Value 2009-2014
Table 17 Forecast Sales of Herbal/Traditional Products: % Value Growth 2009-2014
Euromonitor International
April 2010
List of Contents and Tables
Executive Summary
Below-average Yet Still Positive Performance in 2009
Positive But Also Backward Steps in Deregulation
Market Still Fragmented, Despite Growing Global Consolidation
Distribution Still Under the Control of Pharmacies
Lower Growth Expected in the Short Term
Key Trends and Developments
Consumer Health Affected by Consumers Planning Purchases More Carefully
Deregulation on the One Side, Tougher Legislation on the Other
No Time To Be Sick
More Children, More Older People But More Limited Impact of Demography
Back To Nature
No Real Wind of Change in Distribution for the Moment
More Favourable Ground for the Leading Players
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
A New Agency and New Measures To Shorten the Delay
Belgian Medicines Law Follows European Lead
De-listing Or De-reimbursement
Advertising
Legislation on Advertising Remains Restrictive
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Switch Climate
Regulation of Herbal Products
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Biodiphar NV SA
Strategic Direction
Key Facts
Summary 3 Biodiphar NV SA: Key Facts
Summary 4 Biodiphar NV SA: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 5 Biodiphar NV SA: Competitive Position 2008
Omega Pharma NV
Strategic Direction
Key Facts
Summary 6 Omega Pharma NV: Key Facts
Summary 7 Omega Pharma NV: Operational Indicators
Company Background
Production
Summary 8 Omega Pharma NV: Production Statistics 2005
Competitive Positioning
Summary 9 Omega Pharma NV: Competitive Position 2009
Patch Pharma SA
Strategic Direction
Key Facts
Summary 10 Patch Pharma NV SA: Key Facts
Summary 11 Patch Pharma NV SA: Operational Indicators
Company Background and Production
Competitive Positioning
Pharmaceutiques Trenker, Laboratoires
Strategic Direction
Key Facts
Summary 12 Pharmaceutiques Trenker, Laboratoires: Key Facts
Summary 13 Pharmaceutiques Trenker, Laboratoires: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 14 Pharmaceutiques Trenker, Laboratoires: Competitive Position 2009
Vemedia Pharma NV
Strategic Direction
Key Facts
Summary 15 Vemedia Pharma NV: Key Facts
Summary 16 Vemedia Pharma NV: Operational Indicators
Company Background
Production
Summary 17 Vemedia Pharma NV: Production Statistics 2009
Competitive Positioning
Summary 18 Vemedia Pharma NV: Competitive Position 2009
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Herbal/Traditional Products: Value 2004-2009
Table 13 Sales of Herbal/Traditional Products: % Value Growth 2004-2009
Table 14 Herbal/Traditional Products Company Shares 2005-2009
Table 15 Herbal/Traditional Products Brand Shares 2006-2009
Table 16 Forecast Sales of Herbal/Traditional Products: Value 2009-2014
Table 17 Forecast Sales of Herbal/Traditional Products: % Value Growth 2009-2014
